Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy.
Barratt J, Barbour SJ, Brenner RM, Cooper K, Wei X, Eren N, Floege J, Jha V, Kim SG, Maes B, Phoon RKS, Singh H, Tesař V, Lafayette R; ORIGIN Phase 2b Investigators.
Barratt J, et al.
J Am Soc Nephrol. 2024 Oct 26:10.1681/ASN.0000000541. doi: 10.1681/ASN.0000000541. Online ahead of print.
J Am Soc Nephrol. 2024.
PMID: 39462308